<DrugInformationSummary id="CDR0000491908"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Fulvestrant is a type of hormone therapy called a selective estrogen receptor degrader (or SERD). It binds to the estrogen receptor, blocking estrogen binding and its action on cancer cells. It also targets the estrogen receptor for destruction. This slows or stops the growth of cancer cells that need estrogen to grow.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/fulvestrant">Fulvestrant</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000043053">fulvestrant</TerminologyLink><GlossaryLink ref="CDR0000306498">fulvestrant</GlossaryLink><USBrandNames><USBrandName>Faslodex</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>ful-VES-trunt</TermPronunciation><MediaLink ref="CDR0000710172" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000710171" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=83d7a440-e904-4e36-afb5-cb02b1c919f7&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Fulvestrant</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=83d7a440-e904-4e36-afb5-cb02b1c919f7&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Fulvestrant is approved to be used alone or with other drugs to treat:</Para><ItemizedList Style="bullet" id="_4"><ListItem><Strong><GlossaryTermRef href="CDR0000444971" dictionary="Cancer.gov" audience="Patient">Breast cancer</GlossaryTermRef>.</Strong> It is used: <ItemizedList Style="bullet" id="_5"><ListItem>Alone in <GlossaryTermRef href="CDR0000045269" dictionary="Cancer.gov" audience="Patient">postmenopausal</GlossaryTermRef> women with <GlossaryTermRef href="CDR0000788029" dictionary="Cancer.gov" audience="Patient">hormone receptor–positive</GlossaryTermRef> (HR+) and <GlossaryTermRef href="CDR0000774531" dictionary="Cancer.gov" audience="Patient">HER2-negative</GlossaryTermRef> <GlossaryTermRef href="CDR0000478743" dictionary="Cancer.gov" audience="Patient">advanced cancer</GlossaryTermRef> that has not been treated with <GlossaryTermRef href="CDR0000045110" dictionary="Cancer.gov" audience="Patient">hormone therapy</GlossaryTermRef>.</ListItem><ListItem>Alone in postmenopausal women with HR+ advanced cancer that got worse after treatment with hormone therapy.</ListItem><ListItem>With <GlossaryTermRef href="CDR0000787678" dictionary="Cancer.gov" audience="Patient">ribociclib succinate</GlossaryTermRef> in  postmenopausal women with HR+ and HER2-negative advanced or <GlossaryTermRef href="CDR0000044058" dictionary="Cancer.gov" audience="Patient">metastatic</GlossaryTermRef> cancer. It is used as <GlossaryTermRef href="CDR0000346494" dictionary="Cancer.gov" audience="Patient">first-line</GlossaryTermRef> hormone therapy or  after the cancer got worse during treatment with  hormone therapy.</ListItem><ListItem>With <GlossaryTermRef href="CDR0000768872" dictionary="Cancer.gov" audience="Patient">palbociclib</GlossaryTermRef> or <GlossaryTermRef href="CDR0000791149" dictionary="Cancer.gov" audience="Patient">abemaciclib</GlossaryTermRef> in women with HR+ and HER2-negative advanced or metastatic cancer that got worse after treatment with hormone therapy. </ListItem></ItemizedList></ListItem></ItemizedList><Para id="_3">Fulvestrant is also being studied in the treatment of other types of cancer.</Para>                          
 </Section><Section id="_About"><Title>More About Fulvestrant</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/43053">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.27">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a607031.html">Fulvestrant</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.28"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.29">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_Research"><Title>Research Results and Related Resources</Title><Para><ExternalRef xref="https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies">Targeted Therapy to Treat Cancer</ExternalRef></Para><Para><ExternalRef xref="https://www.cancer.gov/types/breast/breast-hormone-therapy-fact-sheet">Hormone Therapy for Breast Cancer</ExternalRef></Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C1379">Find Clinical Trials for Fulvestrant</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2006-10-05</DateFirstPublished><DateLastModified>2025-01-02</DateLastModified></DrugInformationSummary>
